Alexey V. Emshanov, Denis V. Nesterov, Tatyana N. Sokolova, Priscilla S. Amankwah, & Evgeny N. Imyanitov. (2023). Unexpected "Lazarus response" to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer. Open Exploration Publishing Inc..
Chicago Style (17th ed.) CitationAlexey V. Emshanov, Denis V. Nesterov, Tatyana N. Sokolova, Priscilla S. Amankwah, and Evgeny N. Imyanitov. Unexpected "Lazarus Response" to Single-agent Bevacizumab in Heavily Pretreated Patients with HER2-positive Breast Cancer. Open Exploration Publishing Inc., 2023.
MLA (9th ed.) CitationAlexey V. Emshanov, et al. Unexpected "Lazarus Response" to Single-agent Bevacizumab in Heavily Pretreated Patients with HER2-positive Breast Cancer. Open Exploration Publishing Inc., 2023.